Clinical Trial Update: Velcade for Proliferative Lupus Nephritis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating Velcade (bortezomib) for proliferative lupus nephritis was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lupus Nephritis

Drugs mentioned

• Velcade (bortezomib)

Snippet

Sponsor: The Rogosin Institute | Conditions: Lupus Nephritis, Proteinuria | Phase 4 | Status: WITHDRAWN